The Drug Development Process: An Intensive Seminar

Come to UC Berkeley Extension to understand the processes that are vital to successfully bringing a biotechnology product to market. Recognize the critical roles of each company unit, and gain insight into the integrated and multifunctional nature of drug development. Hear from experts with years of hands-on experience with large and small pharmaceutical, biotechnology and related companies. Leave with knowledge of the entire process, enabling you to understand industry terminology and work more effectively in multidisciplinary teams. Although the focus is on pharmaceuticals, seminar discussions also integrate biologics, diagnostics and devices.

This course is co-sponsored by BayBio and UC Berkeley Extension.

Who Should Attend

This course is designed for subject-matter experts who wish to broaden and advance their careers, executives, nontechnical professionals, investors and others interested in fully understanding the drug development process.

Dates: April 23–27, 2012

Location: UC Berkeley Extension Downtown Center

Address: 425 Market St., 8th Floor (enter on Fremont Street)

Cost: $1,975 (includes all course materials, breakfast and lunch)

ENROLL NOW

http://extension.berkeley.edu/catalog/course94.html?utm_source=baybio&utm_medium=listing&utm_content=newsletter&utm_campaign=112AD785

Course Directors
Velimir Kuftinec, Ph.D., M.B.A., has extensive experience in the pharmaceutical, biotechnology, medical instruction and medical diagnostic markets. He is an expert in business development and licensing, global strategic planning and worldwide marketing.

John M. Young, Ph.D., is a former senior pharmaceutical executive and current consultant with more than 40 years of experience in all aspects of development.

Guest Speakers

P. Michael Dubinsky, has 24 years of experience working with the FDA and 13 years of experience in private industry, focusing on GXP compliance.
Charles Du Mond, Ph.D., is senior vice president, biometrics, at ICON Clinical Research.

David Ellis, M.D., Ph.D., is senior medical director at ARYx Therapeutics. He has extensive experience in designing and conducting clinical trials for many companies.

Diane Gordon, Ph.D., has 28 years of experience as an expert project manager and as an independent consultant for companies such as Syntex and Roche.

Natalie McClure, Ph.D., has 21 years of experience in regulatory affairs, representing numerous companies before the FDA.

Tom Moran, has been active in patent law since 1973. He consults and teaches after recently retiring from Foley and Larner LLP.

Darwin Williams, M.S., has more than 20 years of experience as a quality management consultant specializing in GMP/GLP compliance and training.

Susan Wollowitz, Ph.D., is vice president of chemistry and manufacturing at Medivation. She has more than 20 years of experience in the chemical and pharmaceutical industries.

Mary Alice Yund, Ph.D., has more than 15 years of experience in developmental genetics research at UC Berkeley. She also has 10 years of experience in technology assessment and market research, consulting for the biopharmaceutical industry.